Kyntra Bio, Inc.
Pharmaceutical Preparations · San Francisco, CA, United States
- PrincipalsDavid DeLuciaChief Financial OfficerThane WettigCEO
- CompanyKyntra Bio, Inc.San Francisco, CA, United States
- Phone line+1 (415) 978-1200General business
Kyntra Bio, Inc. is an SEC-registered Nasdaq-listed company (ticker KYNB) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 2
Chief executive
Thane WettigCEO
Finance
David DeLuciaChief Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗David DeLucia — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Thane Wettig — CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Kiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityKazia Therapeutics LtdPharmaceutical Preparations · Sydney Nsw1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capability